Maria L. Belladonna
Via Del Liceo, 1
Perugia, 06123, Italy
Perugia, 06123, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Gallium-integrated HA/CaCO3 scaffold and its effect on gram-positive bacteria and osteoclastogenesis.
Journal: International journal of pharmaceutics
Published: November 07, 2025
Adverse pro-tumorigenic effects of IDO1 catalytic inhibitors mediated by the non-enzymatic function of IDO1 in tumor cells.
Journal: Frontiers in immunology
Published: August 06, 2025
Gallic acid released by a layered double hydroxide-coated scaffold of hydroxyapatite and β-tricalcium phosphate inhibits the osteoclast formation In Vitro.
Journal: Biomaterials and biosystems
Published: May 27, 2025
Equisetum arvense standardized dried extract hinders age-related osteosarcopenia.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 18, 2024
Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells.
Journal: Frontiers in immunology
Published: November 29, 2023
Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function.
Journal: International journal of molecular sciences
Published: September 18, 2023
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma.
Journal: Oncoimmunology
Published: February 03, 2023
The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1.
Journal: Frontiers in immunology
Published: December 30, 2022
The immunosuppression pathway of tumor-associated macrophages is controlled by heme oxygenase-1 in glioblastoma patients.
Journal: International journal of cancer
Published: May 23, 2022
Last Updated: 09/26/2026